1. Home
  2. CISO vs CPIX Comparison

CISO vs CPIX Comparison

Compare CISO & CPIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CISO Global Inc.

CISO

CISO Global Inc.

HOLD

Current Price

$0.42

Market Cap

24.5M

Sector

Technology

ML Signal

HOLD

Logo Cumberland Pharmaceuticals Inc.

CPIX

Cumberland Pharmaceuticals Inc.

HOLD

Current Price

$4.46

Market Cap

34.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CISO
CPIX
Founded
2015
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
24.5M
34.1M
IPO Year
N/A
2009

Fundamental Metrics

Financial Performance
Metric
CISO
CPIX
Price
$0.42
$4.46
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
655.7K
173.2K
Earning Date
11-13-2025
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$27,743,266.00
$41,278,349.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
12.21
52 Week Low
$0.30
$1.85
52 Week High
$3.84
$7.25

Technical Indicators

Market Signals
Indicator
CISO
CPIX
Relative Strength Index (RSI) 29.26 84.23
Support Level $0.42 $2.42
Resistance Level $0.46 $2.73
Average True Range (ATR) 0.05 0.36
MACD 0.01 0.26
Stochastic Oscillator 7.01 96.61

Price Performance

Historical Comparison
CISO
CPIX

About CISO CISO Global Inc.

CISO Global Inc provides cybersecurity services. The services are used to protect client's data, financial information, intellectual property, and business reputation. The services include penetration testing, security remediation, compliance auditing, vulnerability assessment, and others. Geographically, the company operates in U.S., Chile and All other countries. The maximum revenue is generated from U.S.

About CPIX Cumberland Pharmaceuticals Inc.

Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.

Share on Social Networks: